11.39
+0.41(+3.73%)
Currency In USD
| Previous Close | 10.98 |
| Open | 10.91 |
| Day High | 11.55 |
| Day Low | 10.72 |
| 52-Week High | 14.93 |
| 52-Week Low | 3.9 |
| Volume | 1.27M |
| Average Volume | 1.36M |
| Market Cap | 1.11B |
| PE | -6.66 |
| EPS | -1.71 |
| Moving Average 50 Days | 12.39 |
| Moving Average 200 Days | 9.35 |
| Change | 0.41 |
If you invested $1000 in ORIC Pharmaceuticals, Inc. (ORIC) since IPO date, it would be worth $441.99 as of December 04, 2025 at a share price of $11.39. Whereas If you bought $1000 worth of ORIC Pharmaceuticals, Inc. (ORIC) shares 3 years ago, it would be worth $2,833.33 as of December 04, 2025 at a share price of $11.39.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Late-Breaking Oral Presentations in EGFR Atypical and EGFR exon 20 NSCLC at the ESMO Asia Congress 2025
GlobeNewswire Inc.
Dec 03, 2025 9:01 PM GMT
Company to host a conference call and webcast on Saturday, December 6, 2025, at 8:00 pm ETSOUTH SAN FRANCISCO and SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on d
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Poster Presentation in HER2 exon 20 NSCLC at the ESMO Asia Congress 2025
GlobeNewswire Inc.
Dec 01, 2025 1:00 PM GMT
Company to host a conference call and webcast on Saturday, December 6, 2025, at 8:00 pm ETSOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focu
ORIC® Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
GlobeNewswire Inc.
Nov 24, 2025 9:05 PM GMT
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today anno